David J. Robbins, Ph.D.

Dr. David Robbins is a Professor and Endowed Chair in Experimental Therapeutics at Georgetown University. His research is focused on elucidating the roles Wnt and Sonic hedgehog (Shh) signaling pathways play in cancers, such as colorectal cancer and medulloblastoma. Dr. Robbins has served on the editorial boards of the Journal of Biological Chemistry, Current Cancer Therapy Reviews, and Cancer Research. He received his Ph.D. degree from UT Southwestern in Pharmacology, and completed postdoctoral training at UCSF.